Align Technology Stock Today
| ALGN Stock | USD 190.82 3.60 1.92% |
PerformanceSolid
| Odds Of DistressTiny
|
Align Technology is selling at 190.82 as of the 19th of February 2026; that is 1.92 percent increase since the beginning of the trading day. The stock's open price was 187.22. Align Technology has a very small chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. Note, on October 22, 2025, Representative Lisa McClain of US Congress acquired under $15k worth of Align Technology's common stock.
Business Domain Health Care Equipment & Services | IPO Date 26th of March 2023 | Category Healthcare | Classification Health Care |
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. Align Technology, Inc. The company has 71.75 M outstanding shares of which 1.93 M shares are presently shorted by private and institutional investors with about 2.28 trading days to cover. More on Align Technology
Moving against Align Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Align Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO and President and Director | Joseph Hogan | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, SP 500 Index, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Cannabis, Trump Equities, Obamacare Repeal, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsAlign Technology utilizes debt financing to potentially enhance returns on invested capital. The relationship between total debt and total assets provides valuable insight into Align Technology's leverage profile, showing how much of Align Technology's resources are funded through borrowing.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Align Technology (ALGN) is traded on NASDAQ Exchange in USA and employs 21,065 people. Align Technology is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 13.57 B. Align Technology conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 71.75 M outstanding shares of which 1.93 M shares are presently shorted by private and institutional investors with about 2.28 trading days to cover.
Align Technology currently holds about 1.09 B in cash with 593.22 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.96.
Check Align Technology Probability Of Bankruptcy
Ownership AllocationAlign Technology holds a total of 71.75 Million outstanding shares. The majority of Align Technology outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Align Technology to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Align Technology. Please pay attention to any change in the institutional holdings of Align Technology as this could imply that something significant has changed or is about to change at the company. Also note that nearly three million seven hundred eighty-eight thousand four hundred invesors are currently shorting Align Technology expressing very little confidence in its future performance.
Check Align Ownership Details
Align Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Jpmorgan Chase & Co | 2025-06-30 | 1.1 M | |
| Amvescap Plc. | 2025-06-30 | 1.1 M | |
| Federated Hermes Inc | 2025-06-30 | 926.7 K | |
| Disciplined Growth Investors Inc | 2025-06-30 | 845 K | |
| Norges Bank | 2025-06-30 | 820.2 K | |
| Kayne Anderson Rudnick Investment Management Llc | 2025-06-30 | 815.3 K | |
| Veritas Investment Partners (uk) Ltd. | 2025-06-30 | 787.6 K | |
| Bank Of America Corp | 2025-06-30 | 786.6 K | |
| Morgan Stanley - Brokerage Accounts | 2025-06-30 | 763.9 K | |
| Vanguard Group Inc | 2025-06-30 | 8.2 M | |
| Blackrock Inc | 2025-06-30 | 5.1 M |
Align Technology Historical Income Statement
Align Stock Against Markets
Align Technology Corporate Executives
Elected by the shareholders, the Align Technology's board of directors comprises two types of representatives: Align Technology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Align. The board's role is to monitor Align Technology's management team and ensure that shareholders' interests are well served. Align Technology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Align Technology's outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Morici | CFO Finance | Profile |
Already Invested in Align Technology?
The danger of trading Align Technology is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Align Technology is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Align Technology. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Align Technology is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Align Technology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Align Technology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Align Technology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Align Technology Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Align Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in Align Stock, please use our How to Invest in Align Technology guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Will Health Care Equipment & Supplies sector continue expanding? Could Align diversify its offerings? Factors like these will boost the valuation of Align Technology. If investors know Align will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Align Technology data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.359 | Earnings Share 5.65 | Revenue Per Share | Quarterly Revenue Growth 0.053 | Return On Assets |
Investors evaluate Align Technology using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Align Technology's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Align Technology's market price to deviate significantly from intrinsic value.
Understanding that Align Technology's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Align Technology represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Align Technology's market price signifies the transaction level at which participants voluntarily complete trades.